Bevacizumab before cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis of colorectal origin: Analysis of early postoperative complication rate and long term follow-up.
Clarisse Eveno
No relevant relationships to disclose
Guillaume Passot
No relevant relationships to disclose
Diane Goéré
No relevant relationships to disclose
Philippe Soyer
No relevant relationships to disclose
Etienne Gayat
No relevant relationships to disclose
Olivier Glehen
No relevant relationships to disclose
Dominique Elias
No relevant relationships to disclose
Marc Pocard
Consultant or Advisory Role - Roche
Research Funding - Roche